Clinical Trial Update: Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma [Phase 2]

View source ↗

Summary

Phase 2 open-label, single-arm trial evaluating metformin as adjunctive therapy in glioblastoma with IDH-wildtype; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Idh-wildtype

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Milano Bicocca | Conditions: Glioblastoma, IDH-wildtype, Metformin | Phase 2 | Status: RECRUITING